 |
|
|
|
|
|
|
|
APS - FIP
Vaccines 2010
'Recent Developments in
Vaccines' |
|
Tuesday 8th - Wednesday
9th June 2010 |
|
Royal Pharmaceutical Society of
Great Britain, 1 Lambeth High Street, London SE1 7JN |
|
|
|
Programme:
[Tuesday]
[Wednesday]
|
|
Tuesday |
| 08.30 |
|
Registration & Coffee |
|
09.20 |
|
Welcome and
Introduction
Dr Sudaxshina Murdan, School of Pharmacy, University of
London |
|
09.30 |
|
The challenges in the preparation of a vaccine for a pandemic influenza
Dr John Wood,
National Institute for Biological Standards and Control |
|
10.10 |
|
The use of quarantine volunteer studies to speed up vaccine
development for RSV and influenza
Prof John Oxford,
Barts and the London School of Medicine and Dentistry |
|
10.50 |
|
Coffee, Posters and
exhibitors |
|
11.20 |
|
Cell Culture
(Vero) Technology for Pandemic Influenza
Dr Noel Barrett,
Baxter International, USA |
|
12.00 |
|
HIV
Dr
Tomas Hanke, Wetherall Institute of Molecular Medicine,
Oxford |
|
12.40 |
|
Cancer vaccines
Prof Angus Dalgleish, St Georges University, London |
|
13.20 |
|
Lunch, Posters and exhibitors |
|
14.20 |
|
Anti-fungal vaccines
Dr Antonio Cassone,
Instituto Superiore di Sanitá, Italy |
|
15.00 |
|
Mucosal immunity and vaccines
Dr Fabienne Anjuère,
Faculté de Médecine Pasteur, France |
|
15.40 |
|
Coffee, Posters and
exhibitors |
|
16.10 |
|
Vaccines in Biodefence
Dr Diane Williamson,
Defence Science and Technology Laboratory, UK |
|
16.50 |
|
The state of the art in vaccination against allergies
Prof Retro Crameri,
Swiss Institute of Allergy and Asthma Research, Switzerland |
|
17.30 |
|
Wine and Cheese
Reception, Posters and Exhibitors |
|
|
Wednesday |
|
09.00 |
|
Coffee and Speed Networking
Session |
|
09.30 |
|
TB Vaccines
Prof Hazel Dockrell, London School of Hygiene and Tropical
Medicine |
| 10.10 |
|
Vaccination strategies against Alzheimer disease
Dr Antonella Prisco,
Institute of Genetics and Biophysics, CNR, Italy |
|
10.50 |
|
Coffee, Posters
and exhibitors |
|
11.20 |
|
Challenges in
Vaccine Production and Scale-up
Dr Susan Dana Jones, BioProcess Technology Consultants Inc, USA |
|
12.00 |
|
New devices and use of ex vivo human tissue as an interface between
in vitro and in vivo testing
Dr James Birchall, Welsh School of Pharmacy |
12.40 |
|
Plants as vaccines factories
Prof George Lomonossoff,
John Innes Centre |
|
13.20 |
|
Lunch, Posters and
exhibitors |
|
14.20 |
|
Novel Xstalbio vaccine formulations
Dr Johann Partridge,
Xstalbio Ltd |
|
15.00 |
|
Veterinary Vaccines against foot and mouth disease
Dr Satya Parida, Institute of Animal Health |
|
15.40 |
|
Coffee, Posters
and exhibitors |
|
16.10 |
|
Building a Fully Integrated Vaccines Company - A case study
Dan Adams JD, CEO, Protein Sciences Corporation, Meriden,
CT, USA |
|
16.50 |
|
How to licence a
vaccine when human efficacy testing is not possible
Dr Matthew Duchars, PharmAthene Inc, USA |
|
17.30 |
|
Summation and close
Dr Sudaxshina Murdan, School of Pharmacy, University of
London |
|
|
BACK TO EVENT OPTIONS |
|
|
|
Registered in England. No 4245751. Registered Office: 840 Melton Road, Thurmaston, Leicester, LE4 8BN |
| |
